Home/Immunic/Dr. Andreas Rauch, Ph.D.
DA

Dr. Andreas Rauch, Ph.D.

Head of Research

Immunic

Immunic Pipeline

DrugIndicationPhase
Vidofludimus calcium (IMU-838)Relapsing-Remitting Multiple Sclerosis (RRMS)Phase 3
IMU-856Crohn's Disease (CD)Phase 1b
IMU-381 / IMU-935Oncology / Inflammatory DiseasesPreclinical